TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for TX-001HR

BOCA RATON, Fla.--(BUSINESS WIRE)--Mar. 8, 2018-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women ’s healthcare company, today announced the acceptance of the NDA for TX-001HR by the U.S. Food and Drug Administration (FDA). TX-001HR is the...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news